Multi-year contract for mission critical technology and services to transform emergency management in the state TASMANIA--(BUSINESS WIRE)--Telstra and Motorola Solutions (NYSE: MSI) will provide Tasmania’s emergency responders and government organisations with a highly advanced, state-wide mission critical communications network to effectively respond to emergencies.The contract to design, build, operate and maintain Tasmania’s Government Radio Network (TasGRN) will provide enhanced digital communication and vastly improved radio network coverage for Tasmania’s public safety and essential services personnel throughout the state.
Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO reduced the risk of disease recurrence or death by 80%WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISSO is indicated for EGFRm patients whose tumors have exon 19 deletions or exon 21 L858R mutations as detected by an approved test.
The new Quest product is a must-have item in everyone’s home, featuring exclusive design innovation, a suite of tailored wellness features and price points for all budget levelsSANTA BARBARA, Calif.--(BUSINESS WIRE)--Ergomotion, the largest manufacturer of adjustable bases worldwide, has launched Quest, a new product designed to empower a proactive healthy lifestyle with in-home solutions, and their first entry into an e-commerce site with Direct-to-Consumer products. Quest was created to assist everyone on their wellness journey. The line consists of three different models and a modified design to target consumers at all price points. The product line will be available at local retailers and on Ergomotion’s website
![]()
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the first granted patent for an important patent family (i.e., a set of patents filed in various countries to protect an invention) was received by the Company from the Australian Patent Office. The granted patent protects proprietary claims, capturing methods and uses for pancreatic proenzymes to treat cancer, specifically, by targeting and eradicating cancer stem cells (“CSCs”). CSCs represent only a small fraction of the cancer cells within a tumor and can remain dormant for extended periods of time, thereby evading standard treatments like chemotherapy and radiotherapy that target dividing cells. Consequently, a priority for improving cancer treatment and reducing risk of cancer relapse is to develop new strategies that selectively target CSC eradication whilst sparing normal stem cells. This continues to be the focus of ongoing research, as the Company’s lead product candidate, PRP, advances towards clinical trials for the treatment of patients with advanced solid tumors.
Significant improvement in multiple measures of Meibomian gland secretion and associated improvements in contact lens wear timeTEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye diseases, today announced topline results from a phase 2 clinical trial evaluating the company’s investigational therapy for the treatment of contact lens discomfort (CLD). The ECLIPTIC study examining Azura’s lead asset, AZR-MD-001, met its primary endpoints by showing statistically significant improvements in multiple measures of Meibomian gland secretion and patients’ ability to wear contact lenses as desired. Full data from the study will be submitted for presentation at an upcoming scientific meeting.
Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO reduced the risk of disease recurrence or death by 80%WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISSO is indicated for EGFRm patients whose tumors have exon 19 deletions or exon 21 L858R mutations as detected by an approved test.
In collaboration with Australian researchers, The Marine Mammal Center in Sausalito, CA has found that the increasing frequency and severity of storm systems drastically decrease the salinity of coastal waters, causing fatal skin disease in dolphins worldwide.SAUSALITO, Calif.--(BUSINESS WIRE)--Scientists at The Marine Mammal Center in Sausalito, CA – the largest marine mammal hospital in the world – and international colleagues have identified a novel skin disease in dolphins that is linked to climate change. The study is a groundbreaking discovery, as it is the first time since the disease first appeared in 2005 that scientists have been able to link a cause to the condition that affects coastal dolphin communities worldwide. Due to the decreased water salinity brought upon by climate change, the dolphins develop patchy and raised skin lesions across their bodies – sometimes covering upwards of 70 percent of their skin.
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto’s 2020 Argyle Pink Diamonds Tender collection of 62 rare pink, red, blue and violet diamonds from its Argyle mine in Australia has delivered a record result, reflecting their extraordinary rarity and unique provenance. The 2020 collection continued its trajectory of double digit price growth and a record number of participants with successful bidders from eight countries. Whilst bids and values remain confidential, Lot Number 1, the 2.24 carat Argyle Eternity™, the most valuable diamond in the collection and the most valuable Fancy Vivid diamond in the Tender’s 37 year history, was sold to Hong Kong fancy coloured diamond specialist, Kunming Diamonds. Kunming Diamonds was also the successful bidder of other lots in the Tender.
DUBLIN--(BUSINESS WIRE)--The "Australia Mattress Market Outlook to 2023 - by Size, by Type, by Distribution Channel, by Price, by Organized and Unorganized Segment" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive analysis on Mattress market in Australia.The report covers various aspects including introduction, pricing analysis, market overview and genesis, trade scenario, trends and developments, issues and challenges, decision making criteria, competitive landscape and government regulations. The report concludes with future market projection and analyst recommendations highlighting the major opportunities and cautions.
MELBOURNE, Australia--(BUSINESS WIRE)--Hansen Technologies (ASX:HSN) is pleased to announce that the City of Charlotte is now live with the company’s latest release of Hansen CIS. The city provides services to almost one million residents in one of the fastest-growing metropolitan areas in the United States and the most populous city in the state of North Carolina. The city has been a long-standing customer of Hansen since 1997.
BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc. (NASDAQ: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company developing its portfolio of clinical and pre-clinical therapies for the treatment of cancers and infectious diseases, today announced completing enrollment in its Phase 1 bioimaging study of ifabotuzumab in patients with recurrent glioblastoma multiforme (GBM). Ifabotuzumab, or ifab, is the Company’s proprietary anti-EphA3 monoclonal antibody. This trial is supported by funding from the Cure Brain Cancer Foundation. Results from the study, being conducted at the Olivia Newton-John Cancer Research Institute in Heidelberg, Victoria, Australia, are expected in the first half of 2021.
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has appointed Jakob Stausholm as chief executive, effective 1 January 2021. Since joining Rio Tinto as an executive director and chief financial officer in 2018, Mr Stausholm has played a leading role in the Group’s strong performance, maintaining capital allocation discipline and delivering significant shareholder returns, while strengthening the balance sheet.
Part of Splitit’s broader investment in its ‘go to market’ strategySYDNEY--(BUSINESS WIRE)--Splitit Payments Ltd (ASX:SPT), a global instalment payment technology company, has appointed Tyson Hackwood as Head of Market Development, Asia-Pacific. Based in Sydney, Tyson will be responsible for growing the company’s presence in the APAC region.Through the development of a Sales and Partnerships program, Tyson will initially be focused on accelerating acceptance of Splitit’s offering in Australia, before expanding into new markets throughout the region.
HANGZHOU, China--(BUSINESS WIRE)--ZC Rubber, the world’s 10th largest tire manufacturer, unveils massive billboards in 4 world-famous locations covering the United States, Australia, Thailand, and Germany. The tire maker will showcase its Arisun and Westlake Tire brands through the sprawling 25-story, 15,000-square-foot building side LED display wrapping around the American Eagle store as the second launch at the heart of Times Square in New York. The company will also roll out a simultaneous billboard launch located at the Melbourne Galleria in Melbourne, the Palladium Square in Bangkok, and the Potsdamer Platz in Berlin to gain a stronger global presence.
NEW YORK--(BUSINESS WIRE)--FOX News Media has signed Laura Ingraham to a new multi-year deal where she will continue as the host of The Ingraham Angle (weekdays, 10-11 PM/ET) on FOX News Channel (FNC), announced Suzanne Scott, CEO of FOX News Media. In making the announcement, Ms. Scott said, “Laura’s one-of-a-kind expertise and powerful commentary has provided an important voice to millions of Americans as a staple of our primetime lineup and we are thrilled to feature her insightful perspective across our platforms for many years to come.”
CHICAGO--(BUSINESS WIRE)--#EmployeeExperience--SilkRoad Technology, a global software and services platform that helps organizations attract, retain and align people to its business, today announced the release of interview scheduling within SilkRoad Recruiting, a powerful tool that will simplify and automate interview scheduling to speed time to hire and differentiate the candidate experience. As organizations seek to digitize and automate activities in increasingly digital operating models, SilkRoad offers easy-to-use, self-service tools that save time and improve productivity for candidates, recruiters, hiring managers and interview teams alike. Interview scheduling will be integrated with Outlook and Google calendars, which will allow ATS users to set their preferred availability and automate the scheduling process.
Company brings enhanced efficiency to TPCRM programs through market expansion, proprietary research and product enhancementsDENVER--(BUSINESS WIRE)--CyberGRX, provider of the world’s first and largest global cyber risk exchange, demonstrated impressive growth in 2020. In a year marked by seismic shifts and challenges, CyberGRX evolved their proprietary, data-forward approach to third-party cyber risk management (TPCRM), fulfilling a critical market need to prioritize and reduce vendor risk just as the business imperative to embrace digital transformation surged. The strength of CyberGRX’s approach to TPCRM is underscored not only by achieving over 100% revenue growth this year, but also by the 180% increase in validated assessments on the Exchange. Additionally, in the company’s first year in the Australian market
The previously disclosed contract adds courtroom monitoring and transcription services to complete the Courtroom of the Future for approximately 50% of Queensland’s court cases PHOENIX, Ariz.--(BUSINESS WIRE)--VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX Venture Exchange: VQS and OTC Markets: VQSLF), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, today announced an important expansion of services in Asia Pacific to assist in court proceedings and transcription production.
Significantly higher reserves and larger-scale expansion project expected to reposition Rochester as the Company’s cornerstone asset, representing a fundamental step-change for CoeurCHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today announced details of the expansion of its Rochester silver-gold mine in Nevada, reflecting significant reserve growth and the benefits of a larger-scale expansion project. An updated National Instrument 43-101 Technical Report will be filed on SEDAR at www.sedar.com
TORONTO--(BUSINESS WIRE)--Roxgold Inc. (“Roxgold” or the “Company”) (TSX: ROXG) (OTCQX: ROGFF) is pleased to announce that it has received confirmation of the signed exploitation (mining) permit from the government of Côte d’Ivoire to develop and operate the Séguéla Gold Project (“Séguéla”) in Côte d’Ivoire. Alongside this development, Roxgold has commenced early works at Séguéla to protect the project critical path and facilitate a rapid ramp up to full construction next year towards commissioning of Séguéla in 2022.
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has committed to invest $10 million with the world’s largest steel producer China Baowu Steel Group over the next two years in low-carbon steelmaking projects and research. This investment is the next step in advancing the partnership formed between Rio Tinto, China Baowu and Tsinghua University in 2019 to develop and implement new methods to reduce carbon emissions and improve environmental performance across the steel value chain.
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto, a leading global mining and metals company, and Nippon Steel Corporation, Japan’s largest steel producer, have signed a Memorandum of Understanding (MoU) to jointly explore, develop and demonstrate technologies to transition to a low-carbon emission steel value chain. Rio Tinto and Nippon Steel share a long history of working together, with the first shipment of iron ore from Australia to Japan coming from Rio Tinto’s Pilbara operations in 1966 and going to Yawata Works in Kitakyushu, now part of Nippon Steel. With this MoU, Rio Tinto and Nippon Steel are looking to enhance their long-standing relationship by extending it into new areas in support of the shared goal of significantly reducing carbon emissions across the entire steel value chain.
The IRiS Alliance is an exclusive scientific and clinical research collaboration that combines two highly complementary technologies to deliver greater precision in the diagnosis and surgical management of urological cancers.MELBOURNE, Australia & PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’) a biopharmaceutical company developing diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) and
CN Bio’s Lung-on-a-Chip technology will enable research into therapies to prevent interstitial lung disease and long-term lung impairment, following SARS-CoV-2 infectionCAMBRIDGE, England & MELBOURNE, Australia--(BUSINESS WIRE)--CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients. Harnessing CN Bio’s Organ-on-a-Chip technology, the aim of the research is to develop a model capable of recapitulating the fibrosis and tissue remodelling seen in chronic interstitial lung disease, often occurring following SARS-CoV-2 infection. Subsequently, the University will investigate anti-inflammatory, anti-fibrotic and anti-viral agents to treat patients.
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto’s partnership with South Metropolitan TAFE (SM TAFE) and the Western Australian State Government has been globally recognised at the World Federation of Colleges and Polytechnics 2020 Awards of Excellence. The partnership won Gold in the ‘Partnership with Industry’ category for its work in developing and deploying the first nationally recognised vocational qualifications in automation.
Extending delivery of new CBN diaspora remittance rules whilst offering customers another convenient and flexible payout option LAGOS, Nigeria--(BUSINESS WIRE)--WorldRemit, a cross-border digital payments service, today launched a service for customers in Nigeria to receive international transfers in their bank accounts in USD ahead of the Christmas celebrations. This further demonstrates WorldRemit’s ongoing commitment to offering customers easy and convenient ways to send and receive money following the Central Bank of Nigeria’s (CBN) new directive for remittances.
Doosan GridTech, a global EPC leader in energy storage, will deploy a battery storage solution that provides grid stability for Australia's third-largest economy. BRISBANE, Australia--(BUSINESS WIRE)--Vena Energy-Australia has named Doosan GridTech as its engineering, procurement, and construction (EPC) partner to build Queensland's largest energy storage system. This battery energy storage system (BESS) will play a major role in improving grid stability and supporting the state's shift to renewable energy. Located near Wandoan in the state's southwest region, the BESS will have a discharge capacity of 100MW and deliver 150MWh—enough to provide power for 57,000 homes.
Partnership will provide SIA members access to foreign currency exchange and cross-border payment solutionsSYDNEY--(BUSINESS WIRE)--Cambridge Global Payments (“Cambridge”), a FLEETCOR company (NYSE: FLT) and a provider of integrated cross-border payments and currency risk management solutions, is pleased to announce they have been selected by Seafood Industry Australia (“SIA”), the national peak-body representing the Australian seafood industry, as an endorsed provider of foreign currency exchange and international payments solutions for SIA members across Australia.
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today on the progress of the Company, recent developments and forecast for 2021, as the Company prepares for entering clinical development for its lead product candidate, PRP, for the treatment and prevention of metastatic cancer. PRP represents a novel therapeutic approach, targeting and eradicating cancer stem cells, but leaving healthy stem cells alone, making it less toxic compared to current standard treatment options, like chemotherapy and radiotherapy. PRP does not suppress the immune system, and therefore in a post pandemic world, can offer support to cancer sufferers who are at risk of infection.
Already recognized as the world leader in robotic solutions for the solar industry, Ecoppia shows a strong pattern of success in India with another large scaled projectHERZELIYA, Israel--(BUSINESS WIRE)--#Solar--Ecoppia (TASE: ECPA), the pioneer and world leader in robotic solutions for photovoltaic solar, announced today yet another significant project of 450MW signed in October with Azure Power
